GE 2026: Pivoting to Ultrasound Neuromodulation and Hybrid‑Electric Aviation for Growth
GE shifts 2026 strategy to R&D, medical ultrasound for neurodegenerative disease and hybrid‑electric aviation, leveraging grants, equity and key contracts for future growth.
6 minutes to read









